Trials / Completed
CompletedNCT01570660
Phielix et al.: Hepatic Fat Content and Adipokines
Effects of Glimepiride Monotherapy Versus Combined Neteglinide-Pioglitazone Therapy on Insulin Sensitivity in Type 2 Diabetic Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- German Diabetes Center · Academic / Other
- Sex
- All
- Age
- 45 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Thiazoledinediones decrease blood glucose by their insulin-sensitizing properties. Here the investigators examined whether pioglitazone (PIO) improves insulin sensitivity independently of glycemic control and whether adipokines or non-esterfied fatty acids (NEFA) serve as mediators.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pioglitazone | 12 weeks of pioglitazone treatment |
Timeline
- Start date
- 2002-02-01
- Primary completion
- 2012-03-01
- Completion
- 2012-03-01
- First posted
- 2012-04-04
- Last updated
- 2012-04-04
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT01570660. Inclusion in this directory is not an endorsement.